Next Article in Journal
Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
Previous Article in Journal
Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients
Article Menu
Issue 10 (October) cover image

Export Article

Open AccessArticle
Cells 2018, 7(10), 160; https://doi.org/10.3390/cells7100160

A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia

1
UOC Immunologia e Diagnostica Molecolare Oncologica, Istituto Oncologico Veneto—IRCCS, Padova 35128, Italy
2
Department of Biomolecular Medicine, Ghent University, Ghent 9000, Belgium
3
Cancer Research Institute Ghent (CRIG), Ghent 9000, Belgium
4
Dipartimento di Salute della Donna e del Bambino, Università degli Studi di Padova, Padova 35128, Italy
5
Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Universita’ degli Studi di Padova, Padova 35128, Italy
6
Pediatric Oncology Unit of Spedali Civili di Brescia, Brescia 25123, Italy
*
Author to whom correspondence should be addressed.
Received: 10 September 2018 / Revised: 26 September 2018 / Accepted: 4 October 2018 / Published: 9 October 2018
Full-Text   |   PDF [6375 KB, uploaded 9 October 2018]   |  

Abstract

MYC-translocated T-lineage acute lymphoblastic leukemia (T-ALL) is a rare subgroup of T-ALL associated with CDKN2A/B deletions, PTEN inactivation, and absence of NOTCH1 or FBXW7 mutations. This subtype of T-ALL has been associated with induction failure and aggressive disease. Identification of drug targets and mechanistic insights for this disease are still limited. Here, we established a human NOTCH1-independent MYC-translocated T-ALL cell line that maintains the genetic and phenotypic characteristics of the parental leukemic clone at diagnosis. The University of Padua T-cell acute lymphoblastic leukemia 13 (UP-ALL13) cell line has all the main features of the above described MYC-translocated T-ALL. Interestingly, UP-ALL13 was found to harbor a heterozygous R882H DNMT3A mutation typically found in myeloid leukemia. Chromatin immunoprecipitation coupled with high-throughput sequencing for histone H3 lysine 27 (H3K27) acetylation revealed numerous putative super-enhancers near key transcription factors, including MYC, MYB, and LEF1. Marked cytotoxicity was found following bromodomain-containing protein 4 (BRD4) inhibition with AZD5153, suggesting a strict dependency of this particular subtype of T-ALL on the activity of super-enhancers. Altogether, this cell line may be a useful model system for dissecting the signaling pathways implicated in NOTCH1-independent T-ALL and for the screening of targeted anti-leukemia agents specific for this T-ALL subgroup. View Full-Text
Keywords: MYC-translocated leukemia; T-lineage acute lymphoblastic leukemia; NOTCH1-independent; super-enhancers; BRD4 inhibition; targeted therapy MYC-translocated leukemia; T-lineage acute lymphoblastic leukemia; NOTCH1-independent; super-enhancers; BRD4 inhibition; targeted therapy
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Tosello, V.; Milani, G.; Martines, A.; Macri, N.; Van Loocke, W.; Matthijssens, F.; Buldini, B.; Minuzzo, S.; Bongiovanni, D.; Schumacher, R.F.; Amadori, A.; Van Vlierberghe, P.; Piovan, E. A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia. Cells 2018, 7, 160.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top